Skip to main content

Table 2 Longitudinal sequence analysis of Gag immunodominant epitopes at 3 months post infection

From: Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects

  1. a HLA types in parentheses denote the putative restricting HLA. Underlined sections denote putative epitopes
  2. bDominant time indicates that the epitope had an immunodominant response at a specific time point
  3. cAmino acids in the dashed boxes denote mutation sites. 3M = 3 months, 1Y = 1 year
  4. dTo specify the flanking region mutation in the GI11 epitope in subject 5, we only show the N terminal amino acid sequence